Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...men characteristics corresponding to the needs of end-users.
more
Indicators are a representation of reality. They are just numbers on a piece of paper or on a computer screen, but they stand for something far greater – the success of your project. Indicators are usually defined in the context of project planning and show something about or give an indication of... progress towards realising the project goal, without being complete or comprehensive. Of course, there could be other representations of this reality, such as stories (Dart and Davies, 2003) or drawings (Feuerstein, 1986) or photographs (Tijm et al, 2011). However, indicators are a widely accepted way of representing what is being achieved in a programme or project.
more
Mapping Report - Ireland.
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
A Systematic Review and Meta-analysis
Clinical Infectious Diseases® 2016;62(12):1586–94
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Méthodologie pour l’élaboration d’un plan stratégique national
Principales composantes du PSN
Training leaders in public health
IMDP 2016 Training Catalogue
A long and healthy life for all South Africans
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Strengthening Community responses to HIv Treatment and Prevention